A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 19 (3) , 407-418
- https://doi.org/10.1016/j.nbd.2005.01.022
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector deliveryNeurobiology of Disease, 2003
- Intraneural Colchicine Inhibition of Adenoviral and Adeno-associated Viral Vector Remote Spinal Cord Gene DeliveryNeurosurgery, 2003
- When biotoxins are tools of terrorPostgraduate Medicine, 2002
- Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscleGene Therapy, 2002
- Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neuronsNeuroReport, 2001
- Neurotrophic Factor Therapy – Prospects and Problemscclm, 2001
- Gene Therapy for Amyotrophic Lateral Sclerosis and Other Motor Neuron DiseasesHuman Gene Therapy, 2000
- A controlled trial of recombinant methionyl human BDNF in ALSNeurology, 1999
- A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosisNeurology, 1998
- Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage librariesNature Medicine, 1996